
    
      Between March 2014 and March 2016, 200 children with upper gastrointestinal symptoms (4-18
      years) and H. pylori infection will be recruited at Beijing Children Hospital.After the
      informed consents are obtained from the guardians, the children will be randomly classified
      into the two group: 10 days standard triple therapy (Omeprazole 0.8-1.0mg/kg.d,bid,
      Amoxicillin 30-50mg/kg.d bidï¼Œ Clarithromycin 15-20mg/kg.d bid), or 10 days tailored therapy
      including one Proton Pump Inhibitor ( Rabeprazole 0.4-0.5mg/kg.d,bid. or Esomeprazole
      0.8-1.0mg/kg.d,bid) and two antibiotics (Amoxicillin 30-50mg/kg.d bid, Clarithromycin
      15-20mg/kg.d bid, Metronidazole15-20mg/kg.d bid) based on antibiotics susceptibility and
      cytochrome P450 isoenzyme 2C19 genotype. Eradication status will be reassessed in four weeks
      after treatment.
    
  